Prevalence of commonly prescribed medications potentially contributing to urinary symptoms in a cohort of older patients seeking care for incontinence

BMC Geriatrics

Volumn 13, Issue 1, 2013, Pages

  Kashyap, Mandavi ^a   Tu, Le Mai ^b   Tannenbaum, Cara ^a  

^a CENTRE DE RECHERCHE   (Canada)

^b UNIVERSITY INSTITUTE OF GERIATRICS OF SHERBROOKE   (Canada)

Author keywords

Incontinence; Lower urinary tract symptoms; Medication; Older adult

Indexed keywords

PRESCRIPTION DRUG;

AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MALE; MIDDLE AGED; PATIENT PARTICIPATION; POLYPHARMACY; PREVALENCE; RISK FACTOR; URINE INCONTINENCE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT PARTICIPATION; POLYPHARMACY; PRESCRIPTION DRUGS; PREVALENCE; RISK FACTORS; URINARY INCONTINENCE;

EID: 84878715750     PISSN: None     EISSN: 14712318     Source Type: Journal    
DOI: 10.1186/1471-2318-13-57     Document Type: Article

References (32)

1. Urinary incontinence is associated with an increase in falls: a systematic review. Chiarelli PE, Mackenzie LA, Osmotherly PG, Aust J Physiother 2009 55 2 89 95 10.1016/S0004-9514(09)70038-8 19463079
2. Association between the Geriatric Giants of urinary incontinence and falls in older people using data from the Leicestershire MRC Incontinence Study. Foley AL, Loharuka S, Barrett JA, Mathews R, Williams K, McGrother CW, Roe BH, Age Ageing 2012 41 1 35 40 10.1093/ageing/afr125 21948857
3. Prevalence and effect on health-related quality of life of overactive bladder in older Americans: Results from the Epidemiology of Lower Urinary Tract Symptoms Study. Sexton CC, Coyne KS, Thompson C, Bavendam T, Chen CI, Markland A, J Am Geriatr Soc 2011 59 1465 1470 10.1111/j.1532-5415.2011.03492.x 21718275
4. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: Results of the EPIC study. Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S, Coyne K, Kelleher C, Hampel C, Artibani W, Abrams P, Eur Urol 2006 50 1306 1314 10.1016/j.eururo.2006.09.019 17049716
5. Comorbidities associated with bladder dysfunction. Tannenbaum C, Gray M, Hoffstetter S, Cardozo L, Int J Clin Pract 2013 67 105 113 10.1111/ijcp.12085 23305472
6. Fourth International Consultation on Incontinence. Incontinence in the frail elderly: report from the 4th International Consultation on Incontinence. DuBeau CE, Kuchel GA, Johnson T 2nd, Palmer MH, Wagg A, Neurourol Urodyn 2010 29 1 165 178 10.1002/nau.20842 20025027
7. Drug-induced urinary incontinence. Tsakiris P, Oelke M, Michel MC, Drugs Aging 2008 25 541 549 10.2165/00002512-200825070-00001 18582143
8. Effects of estrogen with and without progestin on urinary incontinence. Hendrix SL, Cochrane BB, Nygaard IE, Handa VL, Barnabei VM, Iglesia C, Aragaki A, Naughton MJ, Wallace RB, McNeeley SG, JAMA 2005 293 935 948 10.1001/jama.293.8.935 15728164
9. Postmenopausal hormones and incontinence: the Heart and Estrogen/Progestin Replacement Study. Grady D, Brown JS, Vittinghoff E, Applegate W, Varner E, Snyder T, HERS Research Group, Obstet Gynecol 2001 97 116 120 10.1016/S0029-7844(00)01115-7 11152919
10. Health, Aging and Body Composition Study: The effect of medication use on urinary incontinence in community-dwelling elderly women. Ruby CM, Hanlon JT, Boudreau RM, Newman AB, Simonsick EM, Shorr RI, Bauer DC, Resnick NM, J Am Geriatr Soc 2010 58 1715 1720 10.1111/j.1532-5415.2010.03006.x 20670377
11. Contribution of common medications to lower urinary tract symptoms in men. Wuerstle MC, Van Den Eeden SK, Poon KT, Quinn VP, Hollingsworth JM, Loo RK, Jacobsen SJ, Urologic Diseases in America Project, Arch Intern Med 2011 171 1680 1682 10.1001/archinternmed.2011.475 21987200
12. Alpha-adrenoceptor blocking drugs and female urinary incontinence: prevalence and reversibility. Marshall HJ, Beevers DG, Br J Clin Pharmacol 1996 42 507 509 10.1111/j.1365-2125.1996.tb00016.x 8904625
13. Medical conditions, medications, and urinary incontinence: analysis of a population-based survey. Finkelstein MM, Can Fam Phys 2002 48 96 101
14. Benzodiazepines and the risk of urinary incontinence in frail older persons living in the community. Landi F, Cesari M, Russo A, Onder G, Sgadari A, Bernabei R, Silvernet-HC Study Group, Clin Pharmacol Ther 2002 72 729 734 10.1067/mcp.2002.129318 12496754
15. Medication use and control of urination among community-dwelling older adults. Ruby CM, Hanlon JT, Fillenbaum GG, Pieper CF, Branch LG, Bump RC, J Aging Health 2005 17 661 674 10.1177/0898264305279875 16177455
16. Association of diuretic use and overactive bladder syndrome in older adults: a propensity score analysis. Ekundayo OJ, Markland A, Lefante C, Sui X, Goode PS, Allman RM, Ali M, Wahle C, Thornton PL, Ahmed A, Arch Gerontol Geriatr 2009 49 64 68 10.1016/j.archger.2008.05.002 18752858
17. Severe nonproductive cough and cough-induced stress urinary incontinence in diabetic postmenopausal women treated with ACE inhibitor. Lee YJ, Chiang YF, Tsai JC, Diabetes Care 2000 23 427 428 10.2337/diacare.23.3.427 10868884
18. Incidence rates and risk factors for acute urinary retention: the health professionals follow up study. Meigs JB, Barry MJ, Giovannucci E, Rimm EB, Stampfer MJ, Kawachi I, J Urol 1999 162 376 382 10.1016/S0022-5347(05)68563-1 10411042
19. Nonsteroidal antiinflammatory drug use and lower urinary tract symptoms: results from the Boston area community health survey. Gates MA, Hall SA, Chiu GR, Kupelian V, Fitzgerald MP, Link CL, McKinlay JB, Am J Epidemiol 2011 173 1022 1031 10.1093/aje/kwq473 21357657
20. Commonly used antihypertensives and lower urinary tract symptoms: results from the Boston Area Community Health (BACH) Survey. Hall SA, Chiu GR, Kaufman DW, Wittert GA, Link CL, McKinlay JB, BJU Int 2012 109 11 1676 1684 10.1111/j.1464-410X.2011.10593.x 21951754
21. Associations of Commonly Used Medications with Urinary Incontinence in a Community Based Sample. Hall SA, Yang M, Gates MA, Steers WD, Tennstedt SL, McKinlay JB, J Urol 2012 188 1 183 189 10.1016/j.juro.2012.02.2575 22591967
22. Are commonly used psychoactive medications associated with lower urinary tract symptoms? Hall SA, Maserejian NN, Link CL, Steers WD, McKinlay JB, Eur J Clin Pharmacol 2012 68 783 791 10.1007/s00228-011-1170-9 22138718
23. Calcium channel blocker associated lower urinary tract symptoms in males: an Australian retrospective observational study. Hughes JD, Coles MA, Joyce A, Qual Prim Care 2011 19 223 231 21902901
24. Stress urinary incontinence due to prescription medications: alpha-blockers and angiotensin converting enzyme inhibitors. Menefee SA, Chesson R, Wall LL, Obstet Gynecol 1998 91 853 854 10.1016/S0029-7844(97)00497-3 9572189
25. Incontinence after use of enalapril. Casanova JE, J Urol 1990 143 1237 1238 2378645
26. Creation and testing of the Geriatric Self-Efficacy Index for Urinary Incontinence. Tannenbaum C, Brouillette J, Korner-Bitensky N, Dumoulin C, Corcos J, le Tu M, Lemieux MC, Ouellet S, Valiquette L, J Am Geriatr Soc 2008 56 3 542 547 10.1111/j.1532-5415.2007.01572.x 18179504
27. WHO Collaborating Centre for Drug Statistics Methodology, Anatomical Therapeutic Chemical (ATC) classification index with Defined Daily Dose Geneva: WHO 2003
28. The standardization of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, van Kerrebroeck P, Victor A, Wein A, Standardisation Sub-committee of the International Continence Society, Neurourol Urodyn 2002 21 167 178 10.1002/nau.10052 11857671
29. ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence. Avery K, Donovan J, Peters TJ, Shaw C, Gotoh M, Abrams P, Neurourol Urodyn 2004 23 322 330 10.1002/nau.20041 15227649
30. An algorithm for the operational assessment of adverse drug reactions. I. Background, description, and instructions for use. Kramer MS, Leventhal JM, Hutchinson TA, Feinstein AR, JAMA 1979 242 7 623 632 10.1001/jama.1979. 03300070019017 449002
31. A method for estimating the probability of adverse drug reactions. Naranjo CA, Busto U, Sellers EM, et al. Clin Pharmacol Ther 1981 30 2 239 245 10.1038/clpt.1981.154 7249508
32. In defense of pharmacoepidemiology-embracing the Yin and Yang of drug research. Avorn J, N Engl J Med 2007 357 2219 2221 10.1056/NEJMp0706892 18046025